Paclitaxel oral dosage form soon available.

Hanmi Pharmaceutical company announced on Sept. 19 that an oral dosage form of Paclitaxel, an excellent anticancer agent, had been successfully developed for the first time over the world under a close research cooperation with Korea Chemical Research Institute. Hanmi earlier in 1996 developed its own synthesizing process of Paclitaxel and now has made success in development of its oral dosage ...